HealthTech BioActives (HTBA) has welcomed Miura Partners as its new majority shareholder, which will support the company’s growth in Functional Health, Active Pharmaceutical Ingredients, Taste Modulation and Animal Nutrition. Under its previous owner, The Riverside Company, the manufacturer of citrus flavonoids and active forms of vitamin B12 pursued international expansion and modernization over five years. In the new phase, Miura Partners will drive organic and inorganic initiatives to consolidate HTBA as a leading platform for natural ingredients in health and food.
